Harmony Biosciences Holdings, Inc.
Pitolisant HD
narcolepsy and IH
Countdown
358days
Phase 3 readout · ~ Jun 30, 2027 estimated
What's at stake
Phase 3 trial results for Pitolisant HD in narcolepsy and IH are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“Topline data in 2027; anticipated PDUFA date in 2028”